Time period outcome | Private sample | Private healthcare provision | Public healthcare provision | Results of Cox regression analysis with inclusion of private healthcare as binary exposure variable Multivariate survival analysisa | ||||
---|---|---|---|---|---|---|---|---|
Median (IQR) (days) | Median (IQR) (days) | Number of obs | HR | (95%CI) | P value | Other independent variables | ||
Patients with pulmonary involvement | ||||||||
Health system delay cx sp | 59 | 40 (17–90) | 22 (6–52) | 1399 | 0.81 | (0.58–1.12) | 0.195 | a‡ sx‡ pe p h‡ o‡ r sp.‡ |
Diagnostic delay - presentation to first chest x-ray/CT scan | 35 | 29 (5–59) | 9 (0–32) | 1216 | 0.84 | (0.60–1.18) | 0.307 | sx‡ pe r p h‡ o y‡ |
Treatment initiation delay 1 sp | 83 | 19 (7–64) | 10 (3–34) | 1409 | 1.35 | (0.82–2.21) | 0.235 | a‡ p s‡ c h o y sp.‡ h#p‡ a#o‡ a#sp.‡ (this interaction term contained no smear positive in the youngest age-group) |
Extrapulmonary patients | ||||||||
Health system delay cx | 143 | 61 (25–99) | 46 (20–91) | 1504 | NA | sx e f‡ c‡ y‡ cx cx#m‡ | ||
Diagnostic delay - presentation to first chest x-ray/CT scan | 81 | 54 (19–93) | 27 (6–65) | 1080 | 0.79 | (0.63–0.99) | 0.043 | s‡ sx p‡ y‡ |
All patients | ||||||||
Patient delayb | 39 | 1 (0–28) | 18 (0–68) | 871 | 1.36 | (1.02–2.00) | 0.065 | sx pe ly e d p c o |
Laboratory delay - specimen collection to culture resultc | 53 | 43 (40–53) | 43 (35–52) | 1380 | 0.90 | (0.68–1.20) | 0.474 | sx pe ly‡ e‡ d‡ r s‡ p c o c#sx‡ sx#o‡ |
Treatment initiation delay 2 | 60 | 10 (5–25) | 11 (3–21) | 577 | NA | a sx y‡ sm‡ |